Showing results (61-70 of 246) with videos related to
Sort By:
Pageof 25
AMA Journal of Ethics|March 3, 2023
What Should Be Roles of Federal Clinician Governors in Motivating Equity in Locally Coordinated Triage Protocols?Isabelle M Mikell, Courtney L Savage Hoggard, Harald SchmidtClinical Pharmacokinetics|May 1, 1979
Gilbert's syndrome and drug metabolismA F Macklon, R L Savage, M D RawlinsBiochemistry|September 1, 1981
Purification and characterization of Escherichia coli formamidopyrimidine-DNA glycosylase that excises damaged 7-methylguanine from deoxyribonucleic acidC J Chetsanga, M Lozon, C Makaroff, et al.Drugs - Real World Outcomes|March 31, 2021
Diclofenac and the Risk of Rhabdomyolysis: Analysis of Publications and the WHO Global Pharmacovigilance DatabaseMulugeta Russom, Yodit Fitsum, Abiel Abraham, et al.Infection and Immunity|November 1, 1981
Clinical microbiological, and histological manifestations of Streptobacillus moniliformis-induced arthritis in miceN L Savage, G N Joiner, D W FloreyJournal of the American Medical Informatics Association : JAMIA|March 25, 2017
Are informed policies in place to promote safe and usable EHRs? A cross-industry comparisonErica L Savage, Rollin J Fairbanks, Raj M RatwaniOptometry and Vision Science : Official Publication of the American Academy of Optometry|July 11, 2001
A comparison of noninvasive objective and subjective measurements of the optical density of human ocular mediaG L Savage, C A Johnson, D L HowardCurrent Opinion in Psychology|August 13, 2018
Non-coding genetic variation shaping mental healthJohn P Quinn, Abigail L Savage, Vivien J BubbEuropean Journal of Clinical Pharmacology|May 31, 1978
Paracetamol (acetaminophen) kinetics in patients with Gilber's syndromeA P Douglas, R L Savage, M D RawlinsThe New Zealand Medical Journal|March 14, 1990
Survey of neurological problems with amiodarone in the New Zealand Intensive Medicines Monitoring ProgrammeD M Coulter, I R Edwards, R L SavagePageof 25